PLURABIO

Dr. Inchirah Adala is the founder of PLURABIO. Her impact-driven business tackles how a lack of genetic diversity in drug development testing induces racial disparities in drug efficacy and safety across populations. 

Dr. Inchirah Adala, a Loughborough University alumni, won the Inclusivity Champion award for PLURABIO, which aims to tackle the lack of genetic diversity in drug development testing by producing genetically diverse models, which will increase the development of tailored medicine and reduce racial disparities in drug development.

"Ingenuity Impact provided mentorship and the opportunity to pitch to experienced judges, whose valuable feedback has shaped my business. Furthermore, I believe the prizes awarded through the program will be essential to the company's development."
Inchirah Adala, PLURABIO
©Ingenuity Impact 2024. All rights reserved. Website developed by Seismik.